Validus Holdings, Ltd. ("Validus" or the "Company") VR today reported net income available to Validus common shareholders of $94.6 million, or $1.17 per diluted common share, for the three months ended March 31, 2017, compared to $166.8 million, or $1.98 per diluted common share, for the three months ended March 31, 2016.
Net operating income available to Validus common shareholders was $76.8 million, or $0.95 per diluted common share, for the three months ended March 31, 2017, compared to $121.5 million, or $1.44 per diluted common share, for the three months ended March 31, 2016.
The annualized return on average equity was 10.2% for the three months ended March 31, 2017, compared to 18.1% for the three months ended March 31, 2016. The annualized net operating return on average equity was 8.3% for the three months ended March 31, 2017, compared to 13.2% for the three months ended March 31, 2016.
Book value per common share at March 31, 2017 was $47.54, compared to $46.61 at December 31, 2016. Book value per diluted common share at March 31, 2017 was $45.88, compared to $44.97 at December 31, 2016, reflecting quarterly growth of 2.9%, inclusive of common dividends.
Commenting on the results for the three months ended March 31, 2017, Validus' Chairman and CEO Ed Noonan stated:
"This was another good quarter for the Validus Group. We had $94.6 million in net income, and an annualized return on average equity of 10.2% in the quarter. Our combined ratio of 83.2% reflects our continued commitment to underwriting profits, and most importantly we grew our book value per diluted common share (including dividends) by 2.9% during the quarter."
Income available to Validus common shareholders by segment for the three months ended March 31, 2017 and March 31, 2016 was as follows:
Three Months Ended March 31, | ||||||||||
2017 | 2016 | |||||||||
(Expressed in millions of U.S. dollars, | ||||||||||
except per share information) | ||||||||||
Validus Re - Underwriting income | $ | 71.8 | $ | 98.3 | ||||||
Talbot - Underwriting income | 4.9 | 20.3 | ||||||||
Western World - Underwriting loss | (9.1 | ) | (4.7 | ) | ||||||
Validus' share of AlphaCat income | 6.1 | 8.8 | ||||||||
Total segmental income | 73.7 | 122.7 | ||||||||
Managed net investment income (a) | 36.2 | 27.9 | ||||||||
Corporate expenses | (33.1 | ) | (32.5 | ) | ||||||
Other items and eliminations | 17.8 | 48.7 | ||||||||
Net income available to Validus common shareholders | $ | 94.6 | $ | 166.8 | ||||||
Net income per diluted share available to Validus common shareholders | $ | 1.17 | $ | 1.98 | ||||||
Net operating income available to Validus common shareholders (b) | $ | 76.8 | $ | 121.5 | ||||||
Net operating income per diluted share available to Validus common shareholders (b) | $ | 0.95 | $ | 1.44 | ||||||
(a) |
Managed net investment income relates to our managed investment portfolio. Total net investment income, inclusive of AlphaCat's non-managed portfolio was $40.2 million and $29.5 million for the three months ended March 31, 2017 and 2016, respectively. |
|
(b) |
Net operating income available to Validus common shareholders is presented after tax and is considered a non-GAAP financial measure. A reconciliation of net income available to Validus common shareholders, the most comparable GAAP measure, to net operating income available to Validus common shareholders is presented at the end of this release. |
|
This earnings release should be read in conjunction with the Company's first quarter 2017 investor financial supplement that has been posted to the Investors section of the Company's website located at www.validusholdings.com.
First Quarter 2017 Results
Highlights for the first quarter are as follows:
- Gross premiums written for the three months ended March 31, 2017 were $1,190.9 million compared to $1,172.8 million for the three months ended March 31, 2016, an increase of $18.1 million, or 1.5%. The increase was primarily driven by an increase in the Western World segment and was offset by decreases in the Validus Re and Talbot segments. The decrease in the Validus Re segment was driven by a decline in agriculture premiums of $76.3 million due to lower crop premiums available for reinsurers as a result of recent mergers and acquisitions in the primary insurance space, including the Company's announced acquisition of Crop Risk Services ("CRS"). This decrease was offset by an increase in agriculture premiums of $84.3 million in the Western World segment, which resulted from a new quota-share arrangement between CRS and Validus Re Switzerland. The results of this quota-share arrangement have been presented within the Western World segment in anticipation of these premiums being written by Western World upon closing of the transaction.
- Reinsurance premiums ceded for the three months ended March 31, 2017 were $200.1 million compared to $167.8 million, for the three months ended March 31, 2016, an increase of $32.3 million, or 19.2%. The increase was primarily driven by increases in the Validus Re, Talbot and AlphaCat segments.
- The loss ratio for the three months ended March 31, 2017 was 46.9%, which included $61.2 million of favorable loss reserve development on prior accident years, benefiting the loss ratio by 10.6 percentage points compared to a loss ratio for the three months ended March 31, 2016 of 39.3%, which included $53.7 million of favorable loss reserve development on prior accident years, benefiting the loss ratio by 9.4 percentage points. The loss ratio for the three months ended March 31, 2017 included losses on a single energy non-notable loss event of $19.8 million or 3.4 percentage points of the loss ratio. There were no notable or non-notable loss events occurring during the three months ended March 31, 2016. The favorable development of $61.2 million on prior accident years for the three months ended March 31, 2017 was primarily due to favorable development on attritional losses of $50.6 million and favorable development on event losses of $10.6 million.
- The combined ratio for the three months ended March 31, 2017 and 2016 was 83.2% and 75.1%, respectively, an increase of 8.1 percentage points.
- Managed net investment income from our managed investment portfolio for the three months ended March 31, 2017 was $36.2 million compared to $27.9 million for the three months ended March 31, 2016, an increase of $8.3 million, or 29.6%. The increase was primarily driven by returns on the Company's portfolio of structured securities, of which $3.9 million was generated from a single fixed income fund during the three months ended March 31, 2017 compared to a loss of $2.4 million from the same fund during the three months ended March 31, 2016.
- Net income available to Validus common shareholders for the three months ended March 31, 2017 was $94.6 million compared to $166.8 million for the three months ended March 31, 2016, a decrease of $72.2 million, or 43.3%.
- Net operating income available to Validus common shareholders for the three months ended March 31, 2017 was $76.8 million compared to $121.5 million for the three months ended March 31, 2016, a decrease of $44.7 million, or 36.8%.
- Annualized return on average equity was 10.2% and annualized net operating return on average equity was 8.3% for the three months ended March 31, 2017 compared to 18.1% and 13.2%, respectively, for the three months ended March 31, 2016.
Notable and Non-Notable Losses
The Company defines a notable loss event as an event whereby consolidated net losses and loss expenses aggregate to a threshold greater than or equal to $30.0 million. The Company defines a non-notable loss event as an event whereby consolidated net losses and loss expenses aggregate to a threshold greater than or equal to $15.0 million but less than $30.0 million.
There were no notable loss events occurring during the three months ended March 31, 2017. Losses and loss expenses from a single energy non-notable loss event occurring during the three months ended March 31, 2017 were $19.8 million, or 3.4 percentage points of the loss ratio. Details of this loss by segment are as follows:
First Quarter 2017 Non-Notable Loss Event | ||||||||||||||
(Dollars in thousands) | Validus Re | Talbot | Total | |||||||||||
Net Losses and Loss Expenses | 11,012 | 8,750 | 19,762 | |||||||||||
Less: Reinstatement Premiums, net | (567 | ) | 1,627 | 1,060 | ||||||||||
Net Loss Attributable to Validus | $ | 10,445 | $ | 10,377 | $ | 20,822 | ||||||||
Inclusive of reinstatement premiums payable of $1.1 million, the net loss attributable to the Company from this event was $20.8 million.
There were no notable or non-notable loss events occurring during the three months ended March 31, 2016.
The Company's loss ratio, excluding the impact of the non-notable loss event and the change in prior accident years, for the three months ended March 31, 2017 and 2016 was 54.1% and 48.7%, respectively.
Validus Re Segment
Highlights for the first quarter include the following:
- Gross premiums written for the three months ended March 31, 2017 were $620.5 million compared to $691.7 million for the three months ended March 31, 2016, a decrease of $71.1 million, or 10.3%. Gross premiums written for the three months ended March 31, 2017 included $203.7 million of property premiums, $100.5 million of marine premiums and $316.3 million of specialty premiums, compared to $192.6 million of property premiums, $106.6 million of marine premiums and $392.4 million of specialty premiums for the three months ended March 31, 2016. The increase in the property lines of $11.1 million was primarily driven by new business written of $6.0 million and adjustments to existing business of $3.5 million. The decrease in the marine lines of $6.1 million was primarily due to adjustments to existing business. The decrease in premiums in the specialty lines of $76.2 million was primarily driven by a decline in agriculture premiums.
- Reinsurance premiums ceded for the three months ended March 31, 2017 were $108.8 million compared to $92.5 million for the three months ended March 31, 2016, an increase of $16.3 million, or 17.6%. The increase was driven by an increase in coverage purchased of $8.5 million, a new proportional retrocession program of $5.8 million and the timing of certain reinsurance purchases.
- The loss ratio for the three months ended March 31, 2017 was 39.4%, which included $28.8 million of favorable loss reserve development on prior accident years, benefiting the loss ratio by 13.2 percentage points compared to a loss ratio for the three months ended March 31, 2016 of 34.0%, which included $25.7 million of favorable loss reserve development on prior accident years, benefiting the loss ratio by 10.5 percentage points. The loss ratio for the three months ended March 31, 2017 included losses on a single energy non-notable loss event of $11.0 million or 5.0 percentage points of the loss ratio. There were no notable or non-notable loss events occurring during the three months ended March 31, 2016. The favorable development of $28.8 million on prior accident years for the three months ended March 31, 2017 was primarily due to favorable development on attritional losses of $19.5 million and favorable development on event losses of $9.3 million.
- The combined ratio for the three months ended March 31, 2017 and 2016 was 67.2% and 59.6%, respectively, an increase of 7.6 percentage points.
- Underwriting income for the three months ended March 31, 2017 was $71.8 million compared to $98.3 million for the three months ended March 31, 2016, a decrease of $26.5 million, or 27.0%.
Talbot Segment
Highlights for the first quarter include the following:
- Gross premiums written for the three months ended March 31, 2017 were $247.2 million compared to $266.3 million for the three months ended March 31, 2016, a decrease of $19.1 million, or 7.2%. Gross premiums written for the three months ended March 31, 2017 included $73.3 million of property premiums, $77.3 million of marine premiums and $96.6 million of specialty premiums compared to $69.8 million of property premiums, $88.2 million of marine premiums and $108.3 million of specialty premiums for the three months ended March 31, 2016. The decrease in the marine and specialty lines of $10.9 million and $11.7 million, respectively, was primarily driven by decreases across a number of classes as a result of reductions in participation and non-renewals on various programs due to the current rate environment.
- Reinsurance premiums ceded for the three months ended March 31, 2017 were $92.8 million compared to $87.5 million for the three months ended March 31, 2016, an increase of $5.4 million, or 6.1%. The increase was driven by increases in the property and specialty lines of $5.7 million and $6.0 million, respectively, and was partially offset by a decrease in the marine lines of $6.4 million. The increases in the property and specialty lines were driven by lower premium adjustments on quota share policies during the three months ended March 31, 2017. The decrease in the marine lines was primarily due to higher reinstatement premiums across a number of classes during the three months ended March 31, 2016.
- The loss ratio for the three months ended March 31, 2017 was 54.6%, which included $28.8 million of favorable loss reserve development on prior accident years, benefiting the loss ratio by 14.8 percentage points compared to a loss ratio for the three months ended March 31, 2016 of 48.4%, which included $22.7 million of favorable loss reserve development on prior accident years, benefiting the loss ratio by 11.0 percentage points. The loss ratio for the three months ended March 31, 2017 included losses on a single energy non-notable loss event of $8.8 million or 4.5 percentage points of the loss ratio and other mid-size specialty losses of $18.2 million, or 9.3 percentage points of the loss ratio, primarily related to the Mexican Riots. There were no notable or non-notable loss events occurring during the three months ended March 31, 2016. The favorable development of $28.8 million on prior accident years for the three months ended March 31, 2017 was primarily due to favorable development on attritional losses.
- The combined ratio for the three months ended March 31, 2017 and 2016 was 97.9% and 90.2%, respectively, an increase of 7.7 percentage points.
- Underwriting income for the three months ended March 31, 2017 was $4.9 million compared to $20.3 million for the three months ended March 31, 2016, a decrease of $15.4 million, or 76.1%.
Western World Segment
Highlights for the first quarter include the following:
- Gross premiums written for the three months ended March 31, 2017 were $172.0 million compared to $64.0 million for the three months ended March 31, 2016, an increase of $108.1 million, or 169.0%. Gross premiums written for the three months ended March 31, 2017 included $28.1 million of property premiums, $59.6 million of liability premiums and $84.3 million of specialty premiums, compared to $15.4 million of property premiums and $48.5 million of liability premiums for the three months ended March 31, 2016. The increases in the property and liability lines of $12.7 million and $11.1 million, respectively, was primarily due to the continued build out of product offerings in the short-tail property lines as well as the Validus Specialty Underwriters platform. Also contributing to the increase in the liability lines was an increase in the contract liability lines which was partially offset by decreases resulting from the discontinuation of other underperforming general liability lines. The increase in the specialty lines of $84.3 million was due to new agriculture business written in relation to CRS.
- The loss ratio for the three months ended March 31, 2017 was 77.0%, which included $0.2 million of favorable loss reserve development on prior accident years, benefiting the loss ratio by 0.2 percentage points compared to a loss ratio for the three months ended March 31, 2016 of 64.5%, which included $4.4 million of favorable loss reserve development on prior accident years, benefiting the loss ratio by 7.2 percentage points. The loss ratio for the three months ended March 31, 2017 included U.S.-based weather related losses of $8.1 million, or 8.3 percentage points of the loss ratio, compared to $2.0 million, or 3.3 percentage points of the loss ratio during the three months ended March 31, 2016.
- The combined ratio for the three months ended March 31, 2017 and 2016 was 109.6% and 108.1%, respectively, an increase of 1.5 percentage points. The increase was primarily due to the increase in the loss ratio, which was driven by higher U.S.-based weather related losses and lower favorable development on prior accident years during the three months ended March 31, 2017; partially offset by the decrease in the expense ratio as a result of premium growth in the property and liability lines as well as new agriculture business written during the three months ended March 31, 2017.
- Underwriting loss for the three months ended March 31, 2017 was $9.1 million compared to $4.7 million for the three months ended March 31, 2016, an increase of $4.4 million, or 92.9%.
AlphaCat Segment
Highlights for the first quarter include the following:
- AlphaCat's assets under management were $2.9 billion as at April 1, 2017, compared to $2.7 billion as at January 1, 2017, of which third party assets under management were $2.7 billion as at April 1, 2017, compared to $2.5 billion as at January 1, 2017.
- Revenues earned for the three months ended March 31, 2017 were $5.3 million, of which $4.6 million were earned from third parties, compared to $5.6 million for the three months ended March 31, 2016, of which $4.7 million were earned from third parties.
- Total expenses for the three months ended March 31, 2017 were $4.0 million, compared to $2.4 million for the three months ended March 31, 2016, an increase of $1.5 million, or 62.2%. The increase was driven by a higher allocation of costs to the AlphaCat segment.
- Income before investment income from AlphaCat Funds and Sidecars for the three months ended March 31, 2017 was $1.3 million, compared to $3.2 million for the three months ended March 31, 2016, a decrease of $1.9 million, or 58.5%.
- Investment income from AlphaCat Funds and Sidecars for the three months ended March 31, 2017 was $4.8 million, compared to $5.6 million for the three months ended March 31, 2016, a decrease of $0.8 million or 14.2%.
- Validus' share of AlphaCat income for the three months ended March 31, 2017 was $6.1 million, compared to $8.8 million for the three months ended March 31, 2016, a decrease of $2.7 million, or 30.2%.
Investments
Highlights of our managed portfolio for the first quarter include the following:
- Managed net investment income from our managed investment portfolio for the three months ended March 31, 2017 was $36.2 million compared to $27.9 million for the three months ended March 31, 2016, an increase of $8.3 million, or 29.6%. The increase was primarily driven by returns on the Company's portfolio of structured securities, of which $3.9 million was generated from a single fixed income fund during the three months ended March 31, 2017 compared to a loss of $2.4 million from the same fund during the three months ended March 31, 2016.
- Annualized effective yield for the three months ended March 31, 2017 was 2.27%, compared to 1.79% for the three months ended March 31, 2016, an increase of 48 basis points.
- Net realized losses on managed investments for the three months ended March 31, 2017 were $2.9 million compared to $1.1 million for the three months ended March 31, 2016, an unfavorable movement of $1.8 million.
- The change in net unrealized gains on managed investments for the three months ended March 31, 2017 was $14.3 million compared to $47.1 million for the three months ended March 31, 2016, an unfavorable movement of $32.7 million, or 69.5%. The unfavorable movement was primarily driven by the impact of changes in interest rates on the Company's managed fixed maturity investment portfolio during the three months ended March 31, 2017 as compared to the three months ended March 31, 2016.
Corporate Expenses
Highlights for the first quarter include the following:
- General and administrative expenses for the three months ended March 31, 2017 were $17.2 million compared to $16.2 million for the three months ended March 31, 2016, an increase of $1.0 million or 6.1%.
- Share compensation expenses for the three months ended March 31, 2017 were $3.4 million compared to $4.1 million for the three months ended March 31, 2016, a decrease of $0.7 million or 16.6%.
- Finance expenses, excluding the Company's share of AlphaCat finance expenses from consolidated variable interest entities, for the three months ended March 31, 2017 were $13.9 million compared to $14.3 million for the three months ended March 31, 2016, a decrease of $0.5 million or 3.3%.
- The Company issued $150.0 million of preferred shares in June 2016. Dividends paid on preferred shares during the three months ended March 31, 2017 were $2.2 million.
Shareholders' Equity and Capitalization
As at March 31, 2017, total shareholders' equity was $4.2 billion including $330.6 million of noncontrolling interest and $150.0 million of preferred shares. Shareholders' equity available to Validus common shareholders was $3.8 billion as at March 31, 2017. Book value per common share was $47.54 at March 31, 2017 based on 79,137,590 common shares, compared to $46.61 at December 31, 2016 based on 79,132,252 common shares. Book value per diluted common share was $45.88 at March 31, 2017 based on 82,001,614 diluted common shares, compared to $44.97 at December 31, 2016 based on 82,026,998 diluted common shares, an increase of 2.9%, inclusive of dividends for the three months ended March 31, 2017. Book value per diluted common share is a non-GAAP financial measure. A reconciliation of book value per common share, the most comparable GAAP measure, to book value per diluted common share is presented at the end of this release.
Total capitalization available to Validus at March 31, 2017 was $4.7 billion, including $537.4 million of junior subordinated deferrable debentures and $245.4 million of senior notes. Total capitalization at March 31, 2017 was $6.7 billion, including $1.7 billion of redeemable noncontrolling interest and $330.6 million of noncontrolling interest related to AlphaCat.
Share Repurchases
The Company has not repurchased any common shares during the three months ended March 31, 2017. A summary of the common share repurchases made to date under the Company's previously announced share repurchase programs is as follows:
Common Share Repurchase Activity
(Expressed in thousands of U.S. dollars except for share and per share information) |
||||||||||||||
Cumulative to Date | ||||||||||||||
Share repurchases: | As at March 31, 2017 | As at April 25, 2017 | through April 25, 2017 | |||||||||||
Aggregate purchase price (a) | $ | 2,704,406 | $ | — | $ | 2,704,406 | ||||||||
Common shares repurchased | 80,508,849 | — | 80,508,849 | |||||||||||
Average price (a) | $ | 33.59 | $ | — | $ | 33.59 | ||||||||
(a) |
Share transactions are on a trade date basis through April 25, 2017 and are inclusive of commissions. Average share price is rounded to two decimal places. |
|
Conference Call
The Company will host a conference call for analysts and investors on April 27, 2017 at 10:00 AM (Eastern) to discuss the first quarter 2017 financial results and related matters. The conference call may be accessed by dialing 1-844-309-6712 (toll-free U.S.) or 1-484-747-6926 (international) and entering the passcode 9211 0610. Those who intend to participate in the conference call should register at least ten minutes in advance to ensure access to the call. A telephone replay of the conference call will be available through May 11, 2017, by dialing 1-855-859-2056 (toll-free U.S.) or 1-404-537-3406 (international) and entering the passcode 9211 0610.
This conference call will also be available through a live audio webcast accessible through the Investors section of the Company's website located at www.validusholdings.com. A replay of the webcast will be available at the Investors section of the Company's website through May 11, 2017. In addition, a financial supplement relating to the Company's financial results for the three months ended March 31, 2017 is available in the Investors section of the Company's website.
About Validus Holdings, Ltd.
Validus Holdings, Ltd. ("Validus") is a holding company for reinsurance and insurance operating companies and investment advisors including Validus Reinsurance, Ltd. ("Validus Re"), Talbot Underwriting Ltd. ("Talbot"), Western World Insurance Group, Inc. ("Western World") and AlphaCat Managers, Ltd. ("AlphaCat").
Validus Re is a Bermuda based reinsurer focused primarily on treaty reinsurance. Talbot is a specialty insurance group primarily operating within the Lloyd's insurance market through Syndicate 1183. Western World is a U.S. specialty lines insurance company focused on excess and surplus lines. AlphaCat is a Bermuda based investment adviser managing capital for third parties and Validus in insurance linked securities and other property catastrophe and specialty reinsurance investments.
Validus Holdings, Ltd. Consolidated Balance Sheets As at March 31, 2017 and December 31, 2016 (Expressed in thousands of U.S. dollars, except share and per share information) |
||||||||||
March 31, 2017 |
December 31, 2016 |
|||||||||
Assets | ||||||||||
Fixed maturity investments trading, at fair value (amortized cost: 2017—$5,391,103; 2016—$5,584,599) | $ | 5,365,216 | $ | 5,543,030 | ||||||
Short-term investments trading, at fair value (amortized cost: 2017—$2,785,232; 2016—$2,796,358) | 2,785,226 | 2,796,170 | ||||||||
Other investments, at fair value (cost: 2017—$415,679; 2016—$380,130) | 443,004 | 405,712 | ||||||||
Investments in investment affiliates, equity method (cost: 2017—$83,968; 2016—$84,840) | 94,697 | 100,431 | ||||||||
Cash and cash equivalents | 623,937 | 419,976 | ||||||||
Restricted cash | 92,547 | 70,956 | ||||||||
Total investments and cash | 9,404,627 | 9,336,275 | ||||||||
Premiums receivable | 1,214,745 | 725,390 | ||||||||
Deferred acquisition costs | 292,180 | 209,227 | ||||||||
Prepaid reinsurance premiums | 199,046 | 77,996 | ||||||||
Securities lending collateral | 10,386 | 9,779 | ||||||||
Loss reserves recoverable | 451,856 | 430,421 | ||||||||
Paid losses recoverable | 37,837 | 35,247 | ||||||||
Income taxes recoverable | 6,757 | 4,870 | ||||||||
Deferred tax asset | 45,995 | 43,529 | ||||||||
Receivable for investments sold | 9,302 | 3,901 | ||||||||
Intangible assets | 114,176 | 115,592 | ||||||||
Goodwill | 196,758 | 196,758 | ||||||||
Accrued investment income | 25,962 | 26,488 | ||||||||
Other assets | 127,494 | 134,282 | ||||||||
Total assets | $ | 12,137,121 | $ | 11,349,755 | ||||||
Liabilities | ||||||||||
Reserve for losses and loss expenses | $ | 3,052,745 | $ | 2,995,195 | ||||||
Unearned premiums | 1,612,474 | 1,076,049 | ||||||||
Reinsurance balances payable | 118,119 | 54,781 | ||||||||
Securities lending payable | 10,852 | 10,245 | ||||||||
Deferred tax liability | 3,818 | 3,331 | ||||||||
Payable for investments purchased | 38,486 | 29,447 | ||||||||
Accounts payable and accrued expenses | 171,134 | 587,648 | ||||||||
Notes payable to AlphaCat investors | 446,576 | 278,202 | ||||||||
Senior notes payable | 245,412 | 245,362 | ||||||||
Debentures payable | 537,402 | 537,226 | ||||||||
Total liabilities | $ | 6,237,018 | $ | 5,817,486 | ||||||
Commitments and contingent liabilities | ||||||||||
Redeemable noncontrolling interests | 1,657,630 | 1,528,001 | ||||||||
Shareholders' equity | ||||||||||
Preferred shares (Issued and Outstanding: 2017—6,000; 2016—6,000) | 150,000 | 150,000 | ||||||||
Common shares (Issued: 2017—161,285,411; 2016—161,279,976; Outstanding: 2017—79,137,590; 2016—79,132,252) | 28,225 | 28,224 | ||||||||
Treasury shares (2017—82,147,821; 2016—82,147,724) | (14,376 | ) | (14,376 | ) | ||||||
Additional paid-in capital | 830,346 | 821,023 | ||||||||
Accumulated other comprehensive loss | (22,453 | ) | (23,216 | ) | ||||||
Retained earnings | 2,940,134 | 2,876,636 | ||||||||
Total shareholders' equity available to Validus | 3,911,876 | 3,838,291 | ||||||||
Noncontrolling interests | 330,597 | 165,977 | ||||||||
Total shareholders' equity | $ | 4,242,473 | $ | 4,004,268 | ||||||
Total liabilities, noncontrolling interests and shareholders' equity | $ | 12,137,121 | $ | 11,349,755 | ||||||
Validus Holdings, Ltd. Consolidated Statements of Income For the three months ended March 31, 2017 and 2016 (Expressed in thousands of U.S. dollars, except share and per share information) |
||||||||||
Three Months Ended March 31, | ||||||||||
2017 | 2016 | |||||||||
Revenues | ||||||||||
Gross premiums written | $ | 1,190,857 | $ | 1,172,791 | ||||||
Reinsurance premiums ceded | (200,106 | ) | (167,835 | ) | ||||||
Net premiums written | 990,751 | 1,004,956 | ||||||||
Change in unearned premiums | (415,375 | ) | (433,688 | ) | ||||||
Net premiums earned | 575,376 | 571,268 | ||||||||
Net investment income | 40,214 | 29,461 | ||||||||
Net realized losses on investments | (1,164 | ) | (584 | ) | ||||||
Change in net unrealized gains on investments | 13,348 | 47,444 | ||||||||
Income (loss) from investment affiliates | 5,188 | (4,113 | ) | |||||||
Other insurance related income and other income | 1,330 | 1,413 | ||||||||
Foreign exchange gains | 1,569 | 6,245 | ||||||||
Total revenues | 635,861 | 651,134 | ||||||||
Expenses | ||||||||||
Losses and loss expenses | 269,585 | 224,447 | ||||||||
Policy acquisition costs | 111,628 | 107,193 | ||||||||
General and administrative expenses | 87,924 | 86,208 | ||||||||
Share compensation expenses | 9,491 | 11,237 | ||||||||
Finance expenses | 13,943 | 15,203 | ||||||||
Total expenses | 492,571 | 444,288 | ||||||||
Income before taxes, loss from operating affiliate and (income) attributable to AlphaCat investors | 143,290 | 206,846 | ||||||||
Tax benefit | 3,549 | 2,118 | ||||||||
Loss from operating affiliate | — | (23 | ) | |||||||
(Income) attributable to AlphaCat investors | (7,503 | ) | (4,600 | ) | ||||||
Net income | $ | 139,336 | $ | 204,341 | ||||||
Net (income) attributable to noncontrolling interests | (42,572 | ) | (37,531 | ) | ||||||
Net income available to Validus | 96,764 | 166,810 | ||||||||
Dividends on preferred shares | (2,203 | ) | — | |||||||
Net income available to Validus common shareholders | $ | 94,561 | $ | 166,810 | ||||||
Selected ratios: | ||||||||||
Ratio of net to gross premiums written | 83.2 | % | 85.7 | % | ||||||
Losses and loss expense ratio | 46.9 | % | 39.3 | % | ||||||
Policy acquisition cost ratio | 19.4 | % | 18.8 | % | ||||||
General and administrative expense ratio (a) | 16.9 | % | 17.0 | % | ||||||
Expense ratio | 36.3 | % | 35.8 | % | ||||||
Combined ratio | 83.2 | % | 75.1 | % | ||||||
(a) The general and administrative expense ratio includes share compensation expenses. |
||||||||||
Validus Holdings, Ltd. Segment Information For the three months ended March 31, 2017 and 2016 (Expressed in thousands of U.S. dollars, except share and per share information) |
||||||||||
Validus Re Segment | Three Months Ended March 31, | |||||||||
2017 | 2016 | |||||||||
Underwriting revenues | ||||||||||
Gross premiums written | $ | 620,522 | $ | 691,668 | ||||||
Reinsurance premiums ceded | (108,813 | ) | (92,495 | ) | ||||||
Net premiums written | 511,709 | 599,173 | ||||||||
Change in unearned premiums | (293,297 | ) | (355,342 | ) | ||||||
Net premiums earned | 218,412 | 243,831 | ||||||||
Other insurance related income (loss) | 78 | (315 | ) | |||||||
Total underwriting revenues | 218,490 | 243,516 | ||||||||
Underwriting deductions | ||||||||||
Losses and loss expenses | 86,154 | 82,868 | ||||||||
Policy acquisition costs | 41,256 | 42,259 | ||||||||
General and administrative expenses | 16,832 | 17,179 | ||||||||
Share compensation expenses | 2,477 | 2,901 | ||||||||
Total underwriting deductions | 146,719 | 145,207 | ||||||||
Underwriting income | $ | 71,771 | $ | 98,309 | ||||||
Talbot Segment | Three Months Ended March 31, | |||||||||
2017 | 2016 | |||||||||
Underwriting revenues | ||||||||||
Gross premiums written | $ | 247,175 | $ | 266,317 | ||||||
Reinsurance premiums ceded | (92,824 | ) | (87,458 | ) | ||||||
Net premiums written | 154,351 | 178,859 | ||||||||
Change in unearned premiums | 40,714 | 27,933 | ||||||||
Net premiums earned | 195,065 | 206,792 | ||||||||
Other insurance related income | 755 | 11 | ||||||||
Total underwriting revenues | 195,820 | 206,803 | ||||||||
Underwriting deductions | ||||||||||
Losses and loss expenses | 106,412 | 100,101 | ||||||||
Policy acquisition costs | 43,276 | 44,343 | ||||||||
General and administrative expenses | 38,443 | 38,535 | ||||||||
Share compensation expenses | 2,827 | 3,522 | ||||||||
Total underwriting deductions | 190,958 | 186,501 | ||||||||
Underwriting income | $ | 4,862 | $ | 20,302 | ||||||
Western World Segment | Three Months Ended March 31, | |||||||||
2017 | 2016 | |||||||||
Underwriting revenues | ||||||||||
Gross premiums written | $ | 172,043 | $ | 63,959 | ||||||
Reinsurance premiums ceded | (5,618 | ) | (4,139 | ) | ||||||
Net premiums written | 166,425 | 59,820 | ||||||||
Change in unearned premiums | (69,153 | ) | 1,679 | |||||||
Net premiums earned | 97,272 | 61,499 | ||||||||
Other insurance related income | 241 | 288 | ||||||||
Total underwriting revenues | 97,513 | 61,787 | ||||||||
Underwriting deductions | ||||||||||
Losses and loss expenses | 74,925 | 39,646 | ||||||||
Policy acquisition costs | 20,236 | 14,200 | ||||||||
General and administrative expenses | 10,754 | 12,075 | ||||||||
Share compensation expenses | 692 | 581 | ||||||||
Total underwriting deductions | 106,607 | 66,502 | ||||||||
Underwriting loss | $ | (9,094 | ) | $ | (4,715 | ) | ||||
Validus Holdings, Ltd. Segment Information For the three months ended March 31, 2017 and 2016 (Expressed in thousands of U.S. dollars, except share and per share information) |
||||||||||
AlphaCat Segment | Three Months Ended March 31, | |||||||||
2017 | 2016 | |||||||||
Revenues | ||||||||||
Third party | $ | 4,644 | $ | 4,727 | ||||||
Related party | 631 | 891 | ||||||||
Total revenues | 5,275 | 5,618 | ||||||||
Expenses | ||||||||||
General and administrative expenses | 3,844 | 1,482 | ||||||||
Share compensation expenses | 82 | 141 | ||||||||
Finance expenses | 31 | 808 | ||||||||
Tax benefit | (1 | ) | — | |||||||
Foreign exchange (gains) losses | (1 | ) | 8 | |||||||
Total expenses | 3,955 | 2,439 | ||||||||
Income before investment income from AlphaCat Funds and Sidecars | 1,320 | 3,179 | ||||||||
Investment income (loss) from AlphaCat Funds and Sidecars (a) | ||||||||||
AlphaCat Sidecars | (112 | ) | 124 | |||||||
AlphaCat ILS Funds - Lower Risk (b) | 2,189 | 2,507 | ||||||||
AlphaCat ILS Funds - Higher Risk (b) | 2,367 | 2,436 | ||||||||
BetaCat ILS Funds | 368 | 563 | ||||||||
PaCRe | — | (23 | ) | |||||||
Total investment income from AlphaCat Funds and Sidecars | 4,812 | 5,607 | ||||||||
Validus' share of AlphaCat income | $ | 6,132 | $ | 8,786 | ||||||
(a) |
The investment income from the AlphaCat funds and sidecars is based on equity accounting. |
|
(b) |
Lower risk AlphaCat ILS funds have a maximum permitted portfolio expected loss of less than 7%, whereas higher risk AlphaCat ILS funds have a maximum permitted portfolio expected loss of greater than 7%. Expected loss represents the average annual loss over the set of simulation scenarios divided by the total limit. |
|
Corporate and Investments | Three Months Ended March 31, | |||||||||
2017 | 2016 | |||||||||
Investment income | ||||||||||
Managed net investment income (a) | $ | 36,192 | $ | 27,923 | ||||||
Corporate expenses | ||||||||||
General and administrative expenses | 17,177 | 16,183 | ||||||||
Share compensation expenses | 3,413 | 4,092 | ||||||||
Finance expenses (a) | 13,864 | 14,341 | ||||||||
Dividends on preferred shares | 2,203 | — | ||||||||
Tax benefit (a) | (3,548 | ) | (2,118 | ) | ||||||
Total Corporate expenses | 33,109 | 32,498 | ||||||||
Other items | ||||||||||
Net realized losses on managed investments (a) | (2,892 | ) | (1,086 | ) | ||||||
Change in net unrealized gains on managed investments (a) | 14,349 | 47,078 | ||||||||
Income (loss) from investment affiliates | 5,188 | (4,113 | ) | |||||||
Foreign exchange gains (a) | 1,103 | 6,074 | ||||||||
Other income | 94 | 677 | ||||||||
Total other items | 17,842 | 48,630 | ||||||||
Total Corporate and Investments | $ | 20,925 | $ | 44,055 | ||||||
(a) |
These items exclude the components which are included in Validus' share of AlphaCat and amounts which are consolidated from variable interest entities. |
|
Non-GAAP Financial Measures
In presenting the Company's results, management has included and discussed certain non-GAAP financial measures. The Company believes that these non-GAAP measures, which may be defined and calculated differently by other companies, better explain and enhance the understanding of the Company's results of operations. However, these measures should not be viewed as a substitute for those determined in accordance with U.S. GAAP.
In addition to presenting book value per common share determined in accordance with U.S. GAAP, the Company believes that the following non-GAAP book value financial measures are key financial indicators for evaluating performance and measuring overall growth: book value per diluted common share, book value per diluted common share plus accumulated dividends and tangible book value per diluted common share. A reconciliation of book value per common share, a GAAP financial measure, to the non-GAAP book value financial measures has been included below.
In addition to presenting net income available to Validus common shareholders determined in accordance with U.S. GAAP, the Company believes that showing net operating income available to Validus common shareholders, a non-GAAP financial measure, provides investors with a valuable measure of profitability and enables investors, analysts, rating agencies and other users of its financial information to more easily analyze the Company's results in a manner similar to how management analyzes the Company's underlying business performance.
Net operating income available to Validus common shareholders, a non-GAAP financial measure, is calculated by the addition or subtraction of certain Consolidated Statement of Income line items from net income available to Validus common shareholders, the most directly comparable GAAP financial measure, and measures the performance of the Company's operations without the influence of gains or losses on investments and foreign currencies and other items as noted in the reconciliation below. The Company excludes these items from its calculation of net operating income available to Validus common shareholders because the amount of these gains and losses is heavily influenced by, and fluctuates in part, according to availability of investment market opportunities and other factors. The Company believes these amounts are largely independent of its core underwriting activities and including them distorts the analysis of trends in its operations. The Company believes the reporting of net operating income available to Validus common shareholders enhances the understanding of results by highlighting the underlying profitability of the Company's core (re)insurance operations. This profitability is influenced significantly by earned premium growth, adequacy of the Company's pricing, as well as loss frequency and severity. Over time it is also influenced by the Company's underwriting discipline, which seeks to manage exposure to loss through favorable risk selection and diversification, its management of claims, its use of reinsurance and its ability to manage its expense ratio, which it accomplishes through its management of acquisition costs and other underwriting expenses.
Return on average equity, a GAAP financial measure, and net operating return on average equity, a non-GAAP financial measure, represents the returns generated on common shareholders' equity during the year and are presented below.
Validus Holdings, Ltd. Non-GAAP Financial Measures Reconciliation Book Value per Common Share, Book Value per Diluted Common Share and Tangible Book Value per Diluted Common Share As at March 31, 2017 and December 31, 2016 (Expressed in thousands of U.S. dollars, except share and per share information) |
|||||||||||||
At March 31, 2017 | |||||||||||||
Equity Amount | Common Shares |
Per Share Amount (a) |
|||||||||||
Book value per common share (b) | $ | 3,761,876 | 79,137,590 | $ | 47.54 | ||||||||
Non-GAAP Adjustments: | |||||||||||||
Assumed exercise of outstanding stock options (c)(d) | 614 | 26,136 | |||||||||||
Unvested restricted shares | — | 2,837,888 | |||||||||||
Book value per diluted common share (e) | 3,762,490 | 82,001,614 | $ | 45.88 | |||||||||
Goodwill | (196,758 | ) | — | ||||||||||
Intangible assets | (114,176 | ) | — | ||||||||||
Tangible book value per diluted common share (e) | $ | 3,451,556 | 82,001,614 | $ | 42.09 | ||||||||
Book value per diluted common share (e) | $ | 45.88 | |||||||||||
Accumulated dividends | 11.94 | ||||||||||||
Book value per diluted common share plus accumulated dividends (e) | $ | 57.82 | |||||||||||
At December 31, 2016 | |||||||||||||
Equity Amount | Common Shares |
Per Share Amount (a) |
|||||||||||
Book value per common share (b) | $ | 3,688,291 | 79,132,252 | $ | 46.61 | ||||||||
Non-GAAP Adjustments: | |||||||||||||
Assumed exercise of outstanding stock options (c)(d) | 614 | 26,136 | |||||||||||
Unvested restricted shares | — | 2,868,610 | |||||||||||
Book value per diluted common share (e) | 3,688,905 | 82,026,998 | $ | 44.97 | |||||||||
Goodwill | (196,758 | ) | — | ||||||||||
Intangible assets | (115,592 | ) | — | ||||||||||
Tangible book value per diluted common share (e) | $ | 3,376,555 | 82,026,998 | $ | 41.16 | ||||||||
Book value per diluted common share (e) | $ | 44.97 | |||||||||||
Accumulated dividends | 11.56 | ||||||||||||
Book value per diluted common share plus accumulated dividends (e) | $ | 56.53 | |||||||||||
(a) |
Per share amounts are calculated by dividing the equity amount by the common shares. |
|
(b) |
The equity amount used in the calculation of book value per common share represents total shareholders' equity available to Validus excluding the liquidation value of the preferred shares of $150 million. |
|
(c) |
Using the "as-if-converted" method, assuming all proceeds received upon exercise of stock options will be retained by the Company and the resulting common shares from exercise remain outstanding. |
|
(d) |
At March 31, 2017, the weighted average exercise price for those stock options that had an exercise price lower than book value per share was $23.48 (December 31, 2016: $23.48). |
|
(e) |
Non-GAAP financial measure. |
|
Validus Holdings, Ltd. Non-GAAP Financial Measures Reconciliation
Net Operating Income available to Validus Common Shareholders, Net
Operating Income per Diluted Share Available to For the three months ended March 31, 2017 and 2016 (Expressed in thousands of U.S. dollars, except share and per share information) |
||||||||||
Three Months Ended | ||||||||||
March 31, 2017 |
March 31, 2016 |
|||||||||
Net income available to Validus common shareholders | $ | 94,561 | $ | 166,810 | ||||||
Non-GAAP Adjustments: | ||||||||||
Net realized losses on investments | 1,164 | 584 | ||||||||
Change in net unrealized gains on investments | (13,348 | ) | (47,444 | ) | ||||||
(Income) loss from investment affiliates | (5,188 | ) | 4,113 | |||||||
Foreign exchange gains | (1,569 | ) | (6,245 | ) | ||||||
Other income | (94 | ) | (677 | ) | ||||||
Net income attributable to noncontrolling interests | 728 | 237 | ||||||||
Tax expense (a) | 580 | 4,127 | ||||||||
Net operating income available to Validus common shareholders (b) | $ | 76,834 | $ | 121,505 | ||||||
Earnings per diluted share available to Validus common shareholders | $ | 1.17 | $ | 1.98 | ||||||
Non-GAAP Adjustments: | ||||||||||
Net realized losses on investments | 0.01 | — | ||||||||
Change in net unrealized gains on investments | (0.17 | ) | (0.56 | ) | ||||||
(Income) loss from investment affiliates | (0.06 | ) | 0.05 | |||||||
Foreign exchange gains | (0.02 | ) | (0.07 | ) | ||||||
Other income | — | (0.01 | ) | |||||||
Net income attributable to noncontrolling interests | 0.01 | — | ||||||||
Tax expense (a) | 0.01 | 0.05 | ||||||||
Net operating income per diluted share available to Validus common shareholders (b) | $ | 0.95 | $ | 1.44 | ||||||
Average shareholders' equity available to Validus common shareholders (c) | $ | 3,725,084 | $ | 3,681,701 | ||||||
Annualized return on average equity | 10.2 | % | 18.1 | % | ||||||
Annualized net operating return on average equity (b) | 8.3 | % | 13.2 | % | ||||||
(a) |
Represents the tax expense or benefit associated with the specific country to which the pre-tax adjustment relates to. The tax impact is estimated by applying the statutory rates of applicable jurisdictions, after consideration of other relevant factors including the ability to utilize tax losses carried forward. |
|
(b) |
Non-GAAP financial measure. |
|
(c) |
Average shareholders' equity for the three months ended is the average of the beginning and ending quarter end shareholders' equity balances, excluding the liquidation value of the preferred shares of $150,000. |
|
Cautionary Note Regarding Forward-Looking Statements
This press release may include forward-looking statements, both with respect to the Company and its industry, that reflect our current views with respect to future events and financial performance. Statements that include the words "expect", "intend", "plan", "believe", "project", "anticipate", "will", "may" and similar statements of a future or forward-looking nature identify forward-looking statements. All forward-looking statements address matters that involve risks and uncertainties, many of which are beyond the Company's control. Accordingly, there are or will be important factors that could cause actual results to differ materially from those indicated in such statements and, therefore, you should not place undue reliance on any such statements. We believe that these factors include, but are not limited to, the following: 1) unpredictability and severity of catastrophic events; 2) rating agency actions; 3) adequacy of Validus' risk management and loss limitation methods; 4) cyclicality of demand and pricing in the insurance and reinsurance markets; 5) statutory or regulatory developments including tax policy, reinsurance and other regulatory matters; 6) Validus' ability to implement its business strategy during "soft" as well as "hard" markets; 7) adequacy of Validus' loss reserves; 8) continued availability of capital and financing; 9) retention of key personnel; 10) competition; 11) potential loss of business from one or more major insurance or reinsurance brokers; 12) Validus' ability to implement, successfully and on a timely basis, complex infrastructure, distribution capabilities, systems, procedures and internal controls, and to develop accurate actuarial data to support the business and regulatory and reporting requirements; 13) general economic and market conditions (including inflation, volatility in the credit and capital markets, interest rates and foreign currency exchange rates); 14) the integration of businesses Validus may acquire or new business ventures Validus may start; 15) the effect on Validus' investment portfolios of changing financial market conditions including inflation, interest rates, liquidity and other factors; 16) acts of terrorism or outbreak of war; and 17) availability of reinsurance and retrocessional coverage, as well as management's response to any of the aforementioned factors.
The foregoing review of important factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included herein and elsewhere, including the risk factors included in Validus' most recent reports on Form 10-K and Form 10-Q and other documents of the Company on file with or furnished to the U.S. Securities and Exchange Commission ("SEC"). Any forward-looking statements made in this press release are qualified by these cautionary statements, and there can be no assurance that the actual results or developments anticipated by Validus will be realized or, even if substantially realized, that they will have the expected consequences to, or effects on, Validus or its business or operations. Except as required by law, the Company undertakes no obligation to update publicly or revise any forward-looking statement, whether as a result of new information, future developments or otherwise.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170426006616/en/
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.